inhibition of nr2b-containing n-methyl-d-aspartate receptors (nmdars) in experimental autoimmune encephalomyelitis, a model of multiple sclerosis
Authors
abstract
neurodegeneration is the pathophysiological basis for permanent neurological disabilities in multiple sclerosis (ms); thus neuroprotection is emerging as a therapeutic approach in ms research. modulation of excitotoxicity by inhibition of nmdars has been suggested for neuroprotection, but selective antagonisation of the nr2b subtype of these receptors, a subtype believed to play a more pivotal role in neurodegeneration, has not been tested in ms. in this study inhibition of nr2b-containing nmdar was evaluated on the animal model of ms, experimental autoimmune encephalomyelitis (eae). eae induction was done using mog in c57bl/6 mice. therapeutic administration of different doses of highly selective nr2b-containing nmdar inhibitor (ro25-6981) was compared with memantine (non-selective nmdar antagonist) and vehicle. neurological deficits in eae animals were more efficiently decreased by selective inhibition of nr2b-containing nmdars. histological studies of the spinal cords also showed decreased inflammation, myelin degradation and neuro-axonal degeneration when ro25-6981was administered with higher doses. the effects were dose dependent. regarding the role of nr2b-containing nmdars in excitotoxicity, selective inhibition of these receptor subtypes seems to modulate the neurological disabilities and pathological changes in eae. further elucidation of the exact mechanism of action as well as more experimental studies can suggest nr2b-containing nmdar inhibition as a potentially effective treatment strategy for slowing down the clinical deterioration of disability in ms.
similar resources
Inhibition of NR2B-Containing N-methyl-D-Aspartate Receptors (NMDARs) in Experimental Autoimmune Encephalomyelitis, a Model of Multiple Sclerosis
Neurodegeneration is the pathophysiological basis for permanent neurological disabilities in multiple sclerosis (MS); thus neuroprotection is emerging as a therapeutic approach in MS research. Modulation of excitotoxicity by inhibition of NMDARs has been suggested for neuroprotection, but selective antagonisation of the NR2B subtype of these receptors, a subtype believed to play a more pivotal ...
full textInhibition of NR2B-Containing N-methyl-D-Aspartate Receptors (NMDARs) in Experimental Autoimmune Encephalomyelitis, a Model of Multiple Sclerosis
Neurodegeneration is the pathophysiological basis for permanent neurological disabilities in multiple sclerosis (MS); thus neuroprotection is emerging as a therapeutic approach in MS research. Modulation of excitotoxicity by inhibition of NMDARs has been suggested for neuroprotection, but selective antagonisation of the NR2B subtype of these receptors, a subtype believed to play a more pivotal ...
full textInhibition of NR2B-Containing N-methyl-D-Aspartate Receptors (NMDARs) in Experimental Autoimmune Encephalomyelitis, a Model of Multiple Sclerosis
Neurodegeneration is the pathophysiological basis for permanent neurological disabilities in multiple sclerosis (MS); thus neuroprotection is emerging as a therapeutic approach in MS research. Modulation of excitotoxicity by inhibition of NMDARs has been suggested for neuroprotection, but selective antagonisation of the NR2B subtype of these receptors, a subtype believed to play a more pivotal ...
full textImmunomodulatory Effect of Mesenchymal Stem Cells in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis: A Review Study
Multiple Sclerosis (MS) is a chronic inflammatory and demyelinating disease of the central nervous system that may lead to disability of the patient. Current MS treatment regimens are still insufficient and research is conducted for developing more effective therapies capable of targeting neurodegeneration, inflammation, and demyelination. Recent results of experimental and clinical studies in ...
full textLead inhibition of N-methyl-D-aspartate receptors containing NR2A, NR2C and NR2D subunits.
The potency of Pb2+ inhibition of glutamate-activated currents mediated by N-methyl-D-aspartate (NMDA) receptors was dependent on the subunits composing the receptors when functionally expressed in Xenopus laevis oocytes. Pb2+ reduced the amplitudes of glutamate-activated currents and shifted the agonist EC50 values of NMDA receptors consisting of different subunit compositions. The IC50 values...
full textExpression of NR1/NR2B N-methyl-D-aspartate receptors enhances heroin toxicity in HEK293 cells.
Repeated use of drugs of abuse, namely opiates, has been shown to affect glutamate-releasing neurons. Moreover, blockade of N-methyl-D-aspartate (NMDA) receptors (NMDAR) prevents cell death by apoptosis induced by morphine, a heroin metabolite. Thus, in this article we investigated the involvement of different NMDAR subunits in heroin cytotoxicity. Human embryonic kidney (HEK293) cells, which d...
full textMy Resources
Save resource for easier access later
Journal title:
iranian journal of pharmaceutical researchجلد ۱۳، شماره ۲، صفحات ۶۹۵-۷۰۵
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023